Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Information provided by (Responsible Party):
Maryellen Sun, Dana-Farber Cancer Institute Identifier:
First received: September 5, 2008
Last updated: February 13, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)